|18.60|| +0.20 / +1.09%|
Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. It specializes in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The company markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. It operates through the following segments: Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter OTC products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.
|Raj Rai||Chief Executive Officer|
|Bruce Kutinsky||Chief Operating Officer|
|Duane A. Portwood||Chief Financial Officer & Executive Vice President|
|Mark M. Silverberg||Executive VP-Operations & Technical Services|
|Joseph P. Bonaccorsi||Secretary, Senior Vice President & General Counsel|